Filter
6388
Filtered Results: 6388
Text search:
out-patient
Featured
Recommendations
657
New Publications
1637
Language
Document type
No document type
3679
Studies & Reports
898
Guidelines
891
Manuals
371
Strategic & Response Plan
187
Training Material
129
Fact sheets
121
Situation Updates
52
Brochures
24
Infographics
16
Resource Platforms
13
Online Courses
6
Videos
1
Countries / Regions
India
379
Global
196
Kenya
193
South Africa
190
Sierra Leone
154
Liberia
148
Ethiopia
136
Uganda
126
Nigeria
125
Western and Central Europe
125
Tanzania
103
Malawi
101
Nepal
97
Africa
91
Rwanda
86
Ghana
84
Zambia
82
Bangladesh
79
Latin America and the Carribbean
75
Myanmar / Burma
68
Ukraine
61
Namibia
59
Syria
57
Philippines
51
Eastern Europe
50
Congo, Democratic Republic of
44
Lesotho
42
Zimbabwe
41
South–East Asia Region
40
Germany
37
Guinea
36
Mozambique
36
Cambodia
35
East and Southern Africa
33
West and Central Africa
33
Brazil
32
South Sudan
31
Asia
31
Burkina Faso
30
Senegal
30
Botswana
29
Indonesia
28
Haiti
27
Russia
27
Eastern Europe and Central Asia
24
Venezuela
22
Eswatini/ Swaziland
20
Cameroon
19
Middle East and North Africa
18
Pakistan
17
Colombia
16
Afghanistan
15
Yemen
15
Western Pacific Region
15
Benin
14
Madagascar
13
Iraq
12
Mali
11
Somalia
11
Jordan
11
Lebanon
11
Albania
11
USA
10
Georgia
10
Thailand
9
Sudan
9
Central African Republic
9
Peru
9
Sri Lanka
9
Tajikistan
9
United Kingdom
9
Angola
8
Palestine
8
Côte d’Ivoire / Ivory Coast
7
Argentina
7
Ecuador
7
Laos
7
Moldova
7
Vietnam
7
China
6
Bolivia
6
Mexico
6
Chile
6
Paraguay
6
Southern Africa
6
North America
6
Papua New Guinea
5
North Macedonia
5
Bhutan
5
Iran
5
Jamaica
5
Saudi Arabia
4
Turkey
4
Hungary
4
Poland
4
Niger
3
Gambia
3
El Salvador
3
Greece
3
Armenia
3
Timor Leste/ East Timor
3
Estonia
3
Romania
3
Portugal
3
Spain
3
Guinea-Bissau
2
Morocco
2
Togo
2
Egypt
2
Chad
2
Malaysia
2
Ireland
2
Singapore
2
Libya
2
Guatemala
2
Nicaragua
2
Other region
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Gabon
2
France
2
Mauritius
2
Mauritania
1
Switzerland
1
Serbia
1
Burundi
1
Honduras
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Canada
1
Australia
1
Kazakhstan
1
Uruguay
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2458
Clinical Guidelines
623
Public Health
346
Women & Child Health
270
Key Resources
211
Capacity Building
145
Pharmacy & Technologies
91
Annual Report MEDBOX
2
Toolboxes
Mental Health
580
COVID-19
544
HIV
466
TB
449
Caregiver
279
Ebola
246
AMR
237
Rapid Response
195
NTDs
166
Pharmacy
146
Conflict
141
NCDs
138
Disability
128
Refugee
107
Planetary Health
83
Global Health Education
66
Cholera
41
Natural Hazards
40
Social Ethics
35
Specific Hazards
32
Health Financing Toolbox
31
Zika
27
Polio
24
South Sudan
1
Typhoon
1
Health Financing
1
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
La santé est un droit humain universel et un facteur essentiel de bien-être, de développement économique, de croissance,
de richesse et de prospérité pour tous. Les systèmes de santé jouent un rôle essentiel, car ils protègent, rétablissent et
préservent la santé des ...s et des populations. Un personnel de santé bien formé, motivé et soutenu est la clé de
voûte de tout système de santé et, sans lui, il n’y aurait pas de soins de santé
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Revised and expanded version of the Guidelines
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in An...
Breast cancer is the most common cancer worldwide and the leading cause of cancer deaths among women, disproportionately affecting low- and middle-income countries. The Global Breast Cancer Initiative strives to reduce breast cancer mortality by 2.5 percent per year, which over a 20-year period can ...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT ...s where the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
